Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Immuneering Corp (NASDAQ: IMRX) closed the day trading at $2.66 up 1.92% from the previous closing price of $2.61. In other words, the price has increased by $1.92 from its previous closing price. On the day, 1.55 million shares were traded. IMRX stock price reached its highest trading level at $2.81 during the session, while it also had its lowest trading level at $2.45.
Ratios:
For a better understanding of IMRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.39 and its Current Ratio is at 9.39. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 15, 2024, Reiterated its Buy rating but revised its target price to $15 from $20 previously.
Jefferies Downgraded its Buy to Hold on March 15, 2024, whereas the target price for the stock was revised from $16 to $3.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’24 when Cormorant Asset Management, LP sold 400,000 shares for $2.90 per share. The transaction valued at 1,160,181 led to the insider holds 2,895,273 shares of the business.
Schall Thomas J. bought 2,900 shares of IMRX for $7,385 on Mar 22 ’24. The Director now owns 2,900 shares after completing the transaction at $2.55 per share. On Mar 22 ’24, another insider, Feinberg Peter, who serves as the Director of the company, bought 25,000 shares for $2.55 each. As a result, the insider paid 63,713 and bolstered with 111,766 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMRX now has a Market Capitalization of 78878048 and an Enterprise Value of 23461482.
Stock Price History:
Over the past 52 weeks, IMRX has reached a high of $9.00, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is 80.52%, while the 200-Day Moving Average is calculated to be -16.32%.
Shares Statistics:
Over the past 3-months, IMRX traded about 6.24M shares per day on average, while over the past 10 days, IMRX traded about 15178430 shares per day. A total of 29.27M shares are outstanding, with a floating share count of 21.00M. Insiders hold about 29.18% of the company’s shares, while institutions hold 32.39% stake in the company. Shares short for IMRX as of 1726185600 were 3022085 with a Short Ratio of 0.48, compared to 1723680000 on 1983486. Therefore, it implies a Short% of Shares Outstanding of 3022085 and a Short% of Float of 13.69.
